Salud financiera de hoja de balance de Zeotech

Salud financiera controles de criterios 4/6

Zeotech tiene un patrimonio de los accionistas total de A$12.9M y una deuda total de A$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son A$13.7M y A$784.8K respectivamente.

Información clave

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	AU$2.30m
Patrimonio	AU$12.93m
Total pasivo	AU$784.78k
Activos totales	AU$13.72m

Actualizaciones recientes sobre salud financiera

Recent updates

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Jan 20

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

Nov 21

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Mar 22

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Oct 27

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

Apr 19

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Feb 18

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Jan 25

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$3.1M) de ZEO superan a sus pasivos a corto plazo (A$501.6K).

Pasivo a largo plazo: Los activos a corto plazo de ZEO (A$3.1M) superan a sus pasivos a largo plazo (A$283.2K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: ZEO está libre de deudas.

Reducción de la deuda: ZEO no tenía deudas hace 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: ZEO tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: ZEO tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 22.3% cada año

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de Zeotech

Salud financiera controles de criterios 4/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Zeotech Limited to Be Deleted from Other OTC

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

Recent updates

MD & Director exercised options and sold AU$232k worth of stock

First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023)

New major risk - Financial position

New major risk - Share price stability

Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?

Insider recently sold AU$82k worth of stock

New minor risk - Share price stability

Zeotech Limited Announces CEO Changes, Anticipates to Occur from 1 November 2023

Zeotech Limited, Annual General Meeting, Nov 23, 2023

Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022)

New minor risk - Financial data availability

MD, COO & Director recently sold AU$135k worth of stock

First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022)

Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023

MD, COO & Director exercised options to buy AU$490k worth of stock.

Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology Development

Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)

No independent directors

Zeotech Limited, Annual General Meeting, Nov 28, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021)

Zeotech Limited, Annual General Meeting, Aug 31, 2022

Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured Zeolite

No independent directors

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Zeotech Limited to Be Deleted from Other OTC

Zeotech Limited Announces Pilot Program Update

Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth Plans

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Zeotech Limited announced that it expects to receive AUD 3.7005 million in funding

We Think Zeotech (ASX:ZEO) Can Afford To Drive Business Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More Shares

Zeotech Limited Pilot Plant Program Commences

Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic Zeolites

Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks Like

Zeotech Limited Announces resignation of John Goody as Non-Executive Director

Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural Applications

Full year earnings released

Metalsearch Limited announced that it has received AUD 1.6575 million in funding

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera